Moderna, Inc. financial data

Symbol
MRNA on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 391% % -0.73%
Quick Ratio 12% % -11.95%
Debt-to-equity 28% % -12.32%
Return On Equity -31.4% % -77.59%
Return On Assets -24.44% % -83.07%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 390,679,512 shares 1.5%
Common Stock, Shares, Outstanding 391,000,000 shares 1.6%
Entity Public Float $42,100,000,000 USD 4.7%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 390,000,000 shares 1.3%
Weighted Average Number of Shares Outstanding, Diluted 390,000,000 shares -2.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,232,000,000 USD -56.07%
Research and Development Expense $3,479,000,000 USD -27.93%
General and Administrative Expense $1,061,000,000 USD -17.94%
Costs and Expenses $5,695,000,000 USD -26.74%
Operating Income (Loss) $-3,463,000,000 USD -28.59%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $-3,153,000,000 USD -34%
Income Tax Expense (Benefit) $-37,000,000 USD 71%
Net Income (Loss) Attributable to Parent $-3,116,000,000 USD -40.11%
Earnings Per Share, Basic -8 USD/shares -40.35%
Earnings Per Share, Diluted -8 USD/shares -40.59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,132,000,000 USD -31.14%
Accounts Receivable, after Allowance for Credit Loss, Current $1,046,000,000 USD -33.12%
Inventory, Net $332,000,000 USD -19.42%
Other Assets, Current $56,000,000 USD 22%
Assets, Current $6,598,000,000 USD -31.74%
Deferred Income Tax Assets, Net $81,000,000 USD 0%
Operating Lease, Right-of-Use Asset $738,000,000 USD -5.87%
Goodwill $52,000,000 USD 0%
Other Assets, Noncurrent $530,000,000 USD -4.68%
Assets $12,135,000,000 USD -23.21%
Accounts Payable, Current $267,000,000 USD -28.42%
Employee-related Liabilities, Current $310,000,000 USD 27%
Accrued Liabilities, Current $1,178,000,000 USD -14.39%
Contract with Customer, Liability, Current $163,000,000 USD -56.99%
Liabilities, Current $1,681,000,000 USD -23.63%
Contract with Customer, Liability, Noncurrent $157,000,000 USD 65%
Deferred Income Tax Liabilities, Net $239,000,000 USD -0.83%
Operating Lease, Liability, Noncurrent $660,000,000 USD -2.8%
Other Liabilities, Noncurrent $281,000,000 USD 1.8%
Liabilities $2,805,000,000 USD -27.63%
Accumulated Other Comprehensive Income (Loss), Net of Tax $27,000,000 USD 145%
Retained Earnings (Accumulated Deficit) $8,049,000,000 USD -27.91%
Stockholders' Equity Attributable to Parent $9,330,000,000 USD -21.77%
Liabilities and Equity $12,135,000,000 USD -23.21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-1,037,000,000 USD -4.85%
Net Cash Provided by (Used in) Financing Activities $4,000,000 USD -71.43%
Net Cash Provided by (Used in) Investing Activities $730,000,000 USD 519%
Common Stock, Shares Authorized 1,600,000,000 shares 0%
Common Stock, Shares, Issued 391,000,000 shares 1.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-303,000,000 USD 65%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,134,000,000 USD -31.15%
Deferred Tax Assets, Valuation Allowance $3,084,000,000 USD 39%
Deferred Tax Assets, Gross $3,361,000,000 USD 26%
Operating Lease, Liability $677,000,000 USD -3.29%
Payments to Acquire Property, Plant, and Equipment $117,000,000 USD -40.31%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-3,100,000,000 USD -54.84%
Lessee, Operating Lease, Liability, to be Paid $1,086,000,000 USD -6.46%
Operating Lease, Liability, Current $17,000,000 USD -19.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two $78,000,000 USD 6.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $73,000,000 USD 2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $409,000,000 USD -11.28%
Lessee, Operating Lease, Liability, to be Paid, Year Three $81,000,000 USD 3.8%
Deferred Tax Assets, Operating Loss Carryforwards $424,000,000 USD 371%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 162,000,000 shares 0%
Unrecognized Tax Benefits $240,000,000 USD 3.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $82,000,000 USD 1.2%
Additional Paid in Capital $1,254,000,000 USD 67%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $204,000,000 USD -37.99%
Deferred Tax Assets, Net of Valuation Allowance $277,000,000 USD -38.99%
Share-based Payment Arrangement, Expense $474,000,000 USD 17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%